Search research articles
Contact Us
Filters
Showing results (111-120 of 532) with videos related to
Page
of 54
Sort By:
Annals of the New York Academy of Sciences
|
July 10, 2002
Appetite suppressants as agonist substitution therapies for stimulant dependence
Richard B Rothman, Bruce E Blough, Michael H Baumann
Trends in Pharmacological Sciences
|
October 24, 2006
Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction
Richard B Rothman, Bruce E Blough, Michael H Baumann
Annals of the New York Academy of Sciences
|
November 2, 2017
Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison to MK-801
Michael H Baumann, Richard B Rothman, Syed F Ali
Annals of the New York Academy of Sciences
|
July 21, 1998
Neurochemical and neuroendocrine effects of ibogaine in rats: comparison to MK-801
M H Baumann, R B Rothman, S F Ali
The Journal of Biological Chemistry
|
May 10, 1980
DNA-dependent RNA polymerase from bacteriophage N4 virions. Purification and characterization
S C Falco, W Zehring, L B Rothman-Denes
Journal of Voice : Official Journal of the Voice Foundation
|
October 25, 2002
Spectral changes due to performance environment in singers, nonsingers, and actors
Howard B Rothman, W S Brown, J Ronald LaFond
Pharmacological Reviews
|
March 30, 2011
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A
Christopher W Cunningham, Richard B Rothman, Thomas E Prisinzano
Progress in Brain Research
|
September 6, 2008
Dopamine/serotonin releasers as medications for stimulant addictions
Richard B Rothman, Bruce E Blough, Michael H Baumann
Synapse (New York, N.Y.)
|
August 15, 1998
Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies
W P Rea, R B Rothman, T S Shippenberg
Neuroscience Letters
|
March 16, 2004
A study of bile acids as opioid receptor ligands in rat brain membranes
Nora V Bergasa, Christine M Dersch, Richard B Rothman
Page
of 54
Search research articles
Search
Showing results (111-120 of 532) with videos related to
Sort By:
Page
of 54
Annals of the New York Academy of Sciences
|
July 10, 2002
Appetite suppressants as agonist substitution therapies for stimulant dependence
Richard B Rothman, Bruce E Blough, Michael H Baumann
Trends in Pharmacological Sciences
|
October 24, 2006
Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction
Richard B Rothman, Bruce E Blough, Michael H Baumann
Annals of the New York Academy of Sciences
|
November 2, 2017
Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison to MK-801
Michael H Baumann, Richard B Rothman, Syed F Ali
Annals of the New York Academy of Sciences
|
July 21, 1998
Neurochemical and neuroendocrine effects of ibogaine in rats: comparison to MK-801
M H Baumann, R B Rothman, S F Ali
The Journal of Biological Chemistry
|
May 10, 1980
DNA-dependent RNA polymerase from bacteriophage N4 virions. Purification and characterization
S C Falco, W Zehring, L B Rothman-Denes
Journal of Voice : Official Journal of the Voice Foundation
|
October 25, 2002
Spectral changes due to performance environment in singers, nonsingers, and actors
Howard B Rothman, W S Brown, J Ronald LaFond
Pharmacological Reviews
|
March 30, 2011
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A
Christopher W Cunningham, Richard B Rothman, Thomas E Prisinzano
Progress in Brain Research
|
September 6, 2008
Dopamine/serotonin releasers as medications for stimulant addictions
Richard B Rothman, Bruce E Blough, Michael H Baumann
Synapse (New York, N.Y.)
|
August 15, 1998
Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies
W P Rea, R B Rothman, T S Shippenberg
Neuroscience Letters
|
March 16, 2004
A study of bile acids as opioid receptor ligands in rat brain membranes
Nora V Bergasa, Christine M Dersch, Richard B Rothman
Page
of 54